Breaking News
8 hours ago
Mrudula Kulkarni
Priyanka Patil
Priyanka Patil
Elicio appoints Dr. Preetam Shah as CFO to drive financial strategy and accelerate cancer immunotherapy development.
Mrudula Kulkarni
Novo Nordisk partners with TUL in a $2B deal to develop UBT251, a next-gen therapy for obesity and diabetes.
Mrudula Kulkarni
DBV Technologies secures FDA alignment on Viaskin peanut patch safety data, accelerating BLA submission to H1 2026.
Simantini Singh Deo
Newronika’s AlphaDBS earns CE Mark, introducing real-time adaptive deep brain stimulation for Parkinson’s.
Mrudula Kulkarni